SARS-CoV-2 RBD Recombinant Human mAb (SDT-R005),Starter_specification/price/image

Product Detail
Company Profile

Product Specification

Host	Human
Antigen	SARS-CoV-2
Immunogen	Synthetic Peptide
Accession	P0DTC2
Clone Number	SDT-R005
Antibody Type	Human mAb
Application	ELISA
Reactivity	SARS-CoV-2
Cross Reactivity	Has cross-reactivity in ELISA with: SARS-CoV-2 (BA.2/Omicron) RBD, His Tag (S0A2003) SARS-CoV-2 (BA.2.12.1/Omicron) RBD, His Tag (S0A2015) SARS-CoV-2 (BA.4&BA.5/Omicron) RBD, His Tag (S0A2004) SARS-CoV-2 (BA.2.75/Omicron) RBD
Purification	Protein A
Concentration	4.0mg/ml
Conjugation	Unconjugated
Physical Appearance	Liquid
Storage Buffer	PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300
Stability & Storage	12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution

application	dilution	species
ELISA	0.001-0.05μg/ml	null

Background

Sars-cov-2 (2019-NCOV) infects human respiratory epithelial cells through binding to human ACE2 receptors. Spike protein is a large type I transmembrane protein containing two subunits S1 and S2.S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing cell surface receptors. S2 contains the basic elements required for membrane fusion. S protein plays a key role in inducing neutralizing antibody and T cell responses as well as protective immunity.

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.